2-71124406-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_032601.4(MCEE):c.178A>C(p.Lys60Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000821 in 1,614,158 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00051 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00085 ( 23 hom. )
Consequence
MCEE
NM_032601.4 missense
NM_032601.4 missense
Scores
1
4
13
Clinical Significance
Conservation
PhyloP100: 4.43
Genes affected
MCEE (HGNC:16732): (methylmalonyl-CoA epimerase) The product of this gene catalyzes the interconversion of D- and L-methylmalonyl-CoA during the degradation of branched chain amino acids. odd chain-length fatty acids, and other metabolites. Mutations in this gene result in methylmalonyl-CoA epimerase deficiency, which is presented as mild to moderate methylmalonic aciduria. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.009763122).
BP6
Variant 2-71124406-T-G is Benign according to our data. Variant chr2-71124406-T-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 203812.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Uncertain_significance=1, not_provided=1}. Variant chr2-71124406-T-G is described in Lovd as [Benign].
BS2
High Homozygotes in GnomAdExome4 at 23 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MCEE | NM_032601.4 | c.178A>C | p.Lys60Gln | missense_variant | 2/3 | ENST00000244217.6 | NP_115990.3 | |
MCEE | XM_047446039.1 | c.178A>C | p.Lys60Gln | missense_variant | 2/3 | XP_047301995.1 | ||
MCEE | XM_005264613.3 | c.178A>C | p.Lys60Gln | missense_variant | 2/3 | XP_005264670.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MCEE | ENST00000244217.6 | c.178A>C | p.Lys60Gln | missense_variant | 2/3 | 1 | NM_032601.4 | ENSP00000244217.5 | ||
MCEE | ENST00000413592.5 | c.46A>C | p.Lys16Gln | missense_variant | 1/2 | 2 | ENSP00000391140.1 | |||
MCEE | ENST00000486135.1 | c.-108A>C | 5_prime_UTR_variant | 3/3 | 3 | ENSP00000441569.1 | ||||
MCEE | ENST00000494660.6 | c.-108A>C | 5_prime_UTR_variant | 2/2 | 2 | ENSP00000437361.1 |
Frequencies
GnomAD3 genomes AF: 0.000526 AC: 80AN: 152154Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
80
AN:
152154
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00182 AC: 458AN: 251370Hom.: 10 AF XY: 0.00247 AC XY: 335AN XY: 135884
GnomAD3 exomes
AF:
AC:
458
AN:
251370
Hom.:
AF XY:
AC XY:
335
AN XY:
135884
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000854 AC: 1249AN: 1461886Hom.: 23 Cov.: 34 AF XY: 0.00123 AC XY: 895AN XY: 727244
GnomAD4 exome
AF:
AC:
1249
AN:
1461886
Hom.:
Cov.:
34
AF XY:
AC XY:
895
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000506 AC: 77AN: 152272Hom.: 0 Cov.: 33 AF XY: 0.000819 AC XY: 61AN XY: 74452
GnomAD4 genome
AF:
AC:
77
AN:
152272
Hom.:
Cov.:
33
AF XY:
AC XY:
61
AN XY:
74452
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
259
Asia WGS
AF:
AC:
15
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4Other:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency Benign:2Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Likely benign, criteria provided, single submitter | research | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | - | The homozygous p.Lys60Gln variant in MCEE has been identified in an individual with methylmalonic aciduria (PMID: 17823972), but has also been identified in >1% of South Asian chromosomes and 8 homozygotes by ExAC (http://gnomad.broadinstitute.org/). In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely benign for autosomal recessive methylmalonic aciduria. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2022 | MCEE: BP4, BS1 - |
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Feb 06, 2018 | The c.178A>C; p.Lys60Gln variant (rs147401037) was reported in the homozygous state in one patient with methylmalonic aciduria, ataxia, deteriorated motor function, dysarthria, and mild spastic paraparesis (Gradinger 2007). However, the patient’s protein activity level was normal, as measured by incorporation of propionate into cellular macromolecules (Gradinger 2007). This variant is listed in the genome Aggregation Database (gnomAD) with a South Asian population frequency of 1.5% (identified on 454 out of 30,778 chromosomes, including 10 homozygotes), and is found in the 1000 Genomes Project BEB (Bengali from Bangladesh) population with a frequency of 5.2% (9 out of 172 chromosomes). The lysine at position 60 is highly conserved, considering 13 species, and computational analyses of the effects of the p.Lys60Gln variant on protein structure and function do not predict a deleterious effect (SIFT: tolerated, PolyPhen-2: benign). Based on the available evidence, the p.Lys60Gln variant is likely to be benign. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 08, 2017 | The K60Q variant in the MCEE gene has been reported previously as homozygous in a patient with methylmalonic aciduria (Gradinger et al., 2007). Gradinger et al. reported K60Q in a three year old patient with elevated methylmalonic acid excretion who presented with ataxia, deteriorated motor function, dysarthria, and mild spastic paraparesis. This variant is a non-conservative amino acid substitution of a positively charged Lysine with a neutral, polar Glutamine at a residue that is conserved in mammals. In silico analysis was inconsistent with regard to the effect this variant may have on the protein structure/function. We interpret K60Q as a variant of uncertain significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D
REVEL
Uncertain
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
0.031
.;B
Vest4
0.77
MVP
MPC
0.13
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at